{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:11:10Z","timestamp":1786997470555,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.thromres.2024.04.022","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T02:12:43Z","timestamp":1713924763000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials"],"prefix":"10.1016","volume":"238","author":[{"given":"Lazaros","family":"Karatisidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Zagoridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Mprotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Misidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Pentidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vrachiolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Bezirgianidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Kontomanolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Spanoudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.04.022_bb0005","series-title":"Endotext","article-title":"Definitions, classification, and epidemiology of obesity","author":"Purnell","year":"2000"},{"key":"10.1016\/j.thromres.2024.04.022_bb0010","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.04.022_bb0015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s11239-015-1226-2","article-title":"Body mass index predicts major bleeding risks in patients on warfarin","volume":"40","author":"Ogunsua","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2024.04.022_bb0020","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1538-7836.2007.02565.x","article-title":"Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials","volume":"5","author":"Davidson","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.022_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.amjmed.2023.01.010","article-title":"Direct oral anticoagulants in obese patients with venous thromboembolism: results of an expert consensus panel","volume":"136","author":"Rosovsky","year":"2023","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2024.04.022_bb0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/STROKEAHA.115.011876","article-title":"Body mass index and adverse outcomes in elderly patients with atrial fibrillation: the AMADEUS trial","volume":"47","author":"Senoo","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2024.04.022_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jth.13148","article-title":"Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH","volume":"14","author":"Khorsand","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.022_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.04.022_bb0045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ahj.2015.07.006","volume":"170","author":"Bansilal","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2024.04.022_bb0050","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.amjcard.2017.03.028","volume":"119","author":"Balla","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2024.04.022_bb0055","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/eurheartj\/ehy861","article-title":"Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial","volume":"40","author":"Boriani","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2024.04.022_bb0060","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.amjcard.2018.11.019","article-title":"Impact of body mass index on outcomes in the edoxaban versus warfarin therapy groups in patients underwent cardioversion of atrial fibrillation (from ENSURE-AF)","volume":"123","author":"Lip","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2024.04.022_bb0065","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1007\/s12325-021-01716-8","article-title":"Efficacy, safety, and exposure of apixaban in patients with high body weight or obesity and venous thromboembolism: insights from AMPLIFY","volume":"38","author":"Cohen","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.thromres.2024.04.022_bb0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erc.11.62","article-title":"Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study)","volume":"9","author":"Romualdi","year":"2011","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.thromres.2024.04.022_bb0075","first-page":"416","article-title":"Hokusai-VTE: edoxaban for the treatment of venous thromboembolism","volume":"2013","author":"Said","year":"2013","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.thromres.2024.04.022_bb0080","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00228-023-03572-7","article-title":"Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data","volume":"79","author":"Alalawneh","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.thromres.2024.04.022_bb0085","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.123.066279","volume":"149","author":"Patel","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2024.04.022_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2017.09.029","article-title":"Dronedarone exerts anticoagulant and antiplatelet effects independently of its antiarrhythmic actions","volume":"266","author":"Zafar","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2024.04.022_bb0095","first-page":"739","article-title":"Treatment of venous thromboembolism with rivaroxaban in relation to body weight","volume":"116","author":"Di Nisio","year":"2016","journal-title":"A sub-analysis of the EINSTEIN DVT\/PE studies, Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.022_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2023.12.001","article-title":"Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism","volume":"233","author":"Rueda-Camino","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.04.022_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ajcn\/81.3.543","article-title":"Survival advantages of obesity in dialysis patients","volume":"81","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.thromres.2024.04.022_bb0110","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4065\/mcp.2010.0336","article-title":"The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis","volume":"85","author":"Kalantar-Zadeh","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.thromres.2024.04.022_bb0115","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/heartjnl-2011-300231","article-title":"Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial","volume":"97","author":"Kadakia","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2024.04.022_bb0120","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.116.024976","volume":"134","author":"Nadruz","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2024.04.022_bb0125","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/eurheartj\/ehad083","article-title":"Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox","volume":"44","author":"Butt","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2024.04.022_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4065\/mcp.2009.0562","article-title":"Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years","volume":"85","author":"McAuley","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.thromres.2024.04.022_bb0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4065\/mcp.2009.0777","article-title":"The obesity paradox: perception vs knowledge","volume":"85","author":"Ades","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.thromres.2024.04.022_bb0140","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.mayocp.2016.03.020","article-title":"Prognostic value of adipokines in predicting cardiovascular outcome: explaining the obesity paradox","volume":"91","author":"Wolk","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.thromres.2024.04.022_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-8597-5_12","article-title":"Badimon perfusion chamber: an ex vivo model of thrombosis","volume":"1816","author":"Zafar","year":"2018","journal-title":"Methods Mol. Biol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T04:40:07Z","timestamp":1716007207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"alternative-id":["S0049384824001415"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.04.022","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}